John P. Dahl

John P. Dahl

Auto-generated profile, based on publicly available information

John P. Dahl

Division of Pediatric Otolaryngology Children's Mercy Kansas City Kansas City Missouri USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 June 2020 in American Journal of Medical Genetics Part A
Verified
Journal Article
Open access
PDF file
TWTara L. Wenger
Tara L. Wenger
RBRandall A. Bly
Randall A. Bly
NWNatalie Wu
Natalie Wu
CACatherine M. Albert
Catherine M. Albert
JPJulie Park
Julie Park
WDWilliam B. Dobyns
William B. Dobyns
More than 50 individuals with activating variants in the receptor tyrosine kinase PDGFRB have been reported, separated based on clinical features into solitary myofibromas, infantile myofibromatosis, Penttinen syndrome with premature aging and osteopenia, Kosaki overgrowth syndrome, and fusiform aneurysms. Despite their descriptions as distinct clinical entities, review of previous reports demonstrates substantial phenotypic overlap. We present a case series of 12 patients with activating variants in PDGFRB and review of the literature. We describe five patients with PDGFRB activating variants whose clinical features overlap multiple diagnostic entities. Seven additional patients from a large family had variable expressivity and late‐onset disease, including adult onset features and two individuals with sudden death. Three patients were treated with imatinib and had robust and rapid response, including the first two reported infants with multicentric myofibromas treated with imatinib monotherapy and one with a recurrent p.Val665Ala (Penttinen) variant. Along with previously reported individuals, our cohort suggests infants and young children had few abnormal features, while older individuals had multiple additional features, several of which appeared to worsen with advancing age. Our analysis supports a diagnostic entity of a spectrum disorders due to activating variants in PDGFRB. Differences in reported phenotypes can be dramatic and correlate with advancing age, genotype, and to mosaicism in some individuals.

1 November 2020 in International Journal of Pediatric Otorhinolaryngology
Verified
Journal Article
Closed access
CRCyrus C. Rabbani
Cyrus C. Rabbani
ZPZachary E. Pflum
Zachary E. Pflum
MYMichael J. Ye
Michael J. Ye
JGJohn D. Gettelfinger
John D. Gettelfinger
SSSenthil Sadhasivam
Senthil Sadhasivam
JDJohn P. Dahl
John P. Dahl

31 October 2019 in The Laryngoscope
Verified
Journal Article
Closed access
PDF file
CLC. Carrie Liu
C. Carrie Liu
JSJennifer J. Soares
Jennifer J. Soares
LELeslie Elder
Leslie Elder
LHLeslee Hill
Leslee Hill
MAMatthew Abts
Matthew Abts
SPSanjay R. Parikh
Sanjay R. Parikh

4 September 2020 in The Laryngoscope
Verified
Journal Article
Closed access
PDF file
ALAustin S. Lam
Austin S. Lam
CLCarrie C. Liu
Carrie C. Liu
GDGail H. Deutsch
Gail H. Deutsch
JRJoshua Rivera
Joshua Rivera
JPJonathan A. Perkins
Jonathan A. Perkins
JDJohn P. Dahl
John P. Dahl

26 October 2020 in The Laryngoscope
Verified
Journal Article
Closed access
PDF file
ALAustin S. Lam
Austin S. Lam
EKErin M. Kirkham
Erin M. Kirkham
JDJohn P. Dahl
John P. Dahl
SKSara L. Kinter
Sara L. Kinter
JPJonathan A. Perkins
Jonathan A. Perkins
KSKathleen C.Y. Sie
Kathleen C.Y. Sie

5 August 2021 in International Journal of Pediatric Otorhinolaryngology
Verified
Journal Article
Closed access
JBJuliana Bonilla-Velez
Juliana Bonilla-Velez
KWKathryn B. Whitlock
Kathryn B. Whitlock
SGSheila Ganti
Sheila Ganti
KZKaitlyn Zenner
Kaitlyn Zenner
CCChi Vicky Cheng
Chi Vicky Cheng
JPJonathan A. Perkins
Jonathan A. Perkins